The 2026 Canadian Global Oncology Network (CGON) Conference brought together more than 170 researchers, clinicians, trainees, policymakers, and advocates from across Canada and around the world under the theme “Transforming Health Systems Through Global Oncology”. Co-hosted by the Princess Margaret Global Cancer Program and the University of Toronto Dalla Lana School of Public Health, the conference explored how investments in cancer control can strengthen health systems, advance equity, and improve outcomes for patients globally.
Over two days, attendees engaged with 33 speakers across 11 sessions, featuring keynote presentations, multidisciplinary panels, research showcases, and networking opportunities. Discussions highlighted innovative approaches to health system strengthening, including the impact of AI, the importance of high-quality data, and how sharing lessons learned can advance cancer control both within Canada and abroad. The conference also provided a platform for early-career professionals to share their work and connect with leaders in the field.
As Canada’s leading national forum for global oncology, CGON continues to foster collaboration, mobilize knowledge, and connect stakeholders across Canada who are committed to advancing global cancer control.
SELAC 2026 will virtually convene global leaders, healthcare professionals, researchers, policymakers, patient advocates, and innovators from 13–17 April 2026. Hosted online at www.selac.org, the event continues its mission of advancing collaboration, innovation, and equitable cancer control across Latin America.
This year’s programme will bring together multidisciplinary voices to address key challenges in cancer prevention, treatment, and survivorship, while fostering partnerships that support improved access to care and stronger regional collaboration.
Why Participate?
Shape the future – Contribute to conversations helping define the future of cancer control across Latin America.
Engage in dynamic discussions – Explore advances in areas such as precision oncology, early detection, health equity, and emerging research shaping cancer care.
Share expertise – Present your experience through presentations and panel discussions alongside global experts.
Network globally – Connect with multidisciplinary professionals, researchers, policymakers, and patient advocates to spark collaborations that transcend borders.
Drive policy impact – Help inform actionable strategies aimed at improving cancer care access and outcomes in underserved communities.
In this episode of The Lancet in conversation with, Dr Susannah Stanway reflects on the growing role of London Global Cancer Week in bringing the global oncology community together. Speaking with editors from The Lancet, she explores how collaboration across disciplines and countries can drive progress in cancer prevention, diagnosis, and treatment, while highlighting the importance of equity, evidence-based care, and coordinated global action in improving outcomes for patients worldwide.
A series of London Global Cancer Week interviews featuring speakers and partners is now available on the ecancer network—watch the full collection here.
Dr Susannah Stanway gives an overview of the London Global Cancer Week 2025 meeting that she co-convened.
She begins by discussing how vital it is to bring all the partners and stakeholders together, such as: healthcare, government, faith leaders, economists, industry and patients with lived experience.
Dr Stanway covers some of the areas within international crises that sessions have focussed on including conflict, climate change, artificial intelligence and finances.
London Global Cancer Week was proud to be given the opportunity to give an intervention at the Rays of Hope Forum organised by the Government of Ethiopia and the IAEA at the African Union June 30th and July 1st 2025.
The programme highlighted the work being done by the IAEA “to support Member States in establishing or expanding their medical imaging, nuclear medicine and radiotherapy capabilities to improve access to services particularly in countries that lack this life-saving treatment”
Highlights included a significant partnership signed with St Jude Hospital, hearing progress from anchor centers around the world and a fantastic session on financing for cancer care showcasing innovative models.
Following last year’s successful launch of the WRAD concept during the London Global Cancer Week event in November, I am thrilled to share further details on next steps to support the establishment of a World Radiotherapy Awareness Day. The launch event received endorsements from major radiotherapy professional bodies worldwide, including AORTIC, ASTRO, ALATRO, CACA, ESTRO, FARO, MESTRO, SIOP, PROS, UICC, and the RCR, as well as support from industrial partners. You can see more from it here –https://www.globalradiotherapy.org/post/historic-initiative-launched-world-radiotherapy-awareness-day-takes-shape
We are pleased to invite you to register for the World Radiotherapy Awareness Day (WRAD) planning meeting. The official launch of WRAD will take place this year, and we need your input. Please join this initiative and help bring this important campaign to life. We have a few requests as follows:
Please register
Please share the registration link through your community
SELAC 2025 will virtually convene global leaders, healthcare professionals, researchers, policymakers, patient advocates, and innovators from March 17 to 21th 2025, in www.selac.org under the theme “Equity, Innovation, and Collaboration: Transforming Cancer Control in Latin America”.
This year’s program will focus on bridging gaps in cancer prevention, treatment, and survivorship while fostering partnerships to address regional challenges.
Why Participate?
Shape the future.
Engage in dynamic discussions on cutting-edge research, precision oncology, early detection, and health equity.
Share expertise presenting your experience through presentations, and/or panel discussions.
Network globally connecting with multidisciplinary professionals and other stakeholders to spark collaborations and developments that transcend borders.
Drive Policy Impact contributing to actionable strategies for improving cancer care access and outcomes in underserved communities.
LGCW was invited to run a joint session with the China Anti Cancer Association during the 2024 Chinese Congress on Holistic Integrative Oncology in conjunction with the 4th International Congress of the Asian Oncology Society help in Xi’an, China in November. This multidisciplinary session featured talks from 3 LGCW steering group members (Prof Myrna Doumit, Prof Chris Jackson and Dr Susie Stanway) alongside local speakers on a range of topics pertinent to cancer care across the continuum.
London Global Cancer Week was delighted to have been asked to participate in the Global Health Catalyst meeting and 19th SAARC Federation of Oncologists, Bangladesh International Cancer Congress 2024 held in Dhaka on December 12th 2024
In November 2015 the Royal Society of Medicine’s Oncology Section hosted a meeting. Its focus was the state of cancer control in low and middle income countries; the regions of the world that see over half of the new cancer cases of cancer and nearly 70% of cancer deaths. This meeting was so successful that it subsequently ran annually”. At 3pm (GMT) on Sunday 15 November , despite being separated by the impact of the Coronavirus pandemic 40 researchers and clinicians will join together to launch a UK Global Cancer network.
“We are really excited about uniting those UK colleagues interested in cancer control in low- and middle- income countries and fragile countries together to work collaboratively ” Dr Susannah Stanway
Co chaired by Professor Richard Cowan ( Consultant in Clinical Oncology and Director of The Christie School of Oncology , The Christie NHS Foundation Trust Manchester) and Dr Susannah Stanway(Consultant Medical Oncology, Breast Unit, Royal Marsden NHS Foundation Trust, Surrey), the mission of the Network will be to enhance the UK’s contribution to cancer care in LMICs by bringing together the talent, resources and enthusiasm of individuals and organisations within the UK in a more strategic and collaborative body, with the intention of improving the outcome and experience of people affected by cancer in low and middle income countries.
“The UK GCN is something we have been waiting too long to appear. We now have an opportunity to draw on the wealth of experience, expertise and enthusiasm of colleagues across the UK to enhance our impact on the ever increasing burden of cancer in LMICs” – Professor Richard Cowan
This meeting will be first event in London Global Cancer Week 2020 (www.lgcw.org.uk) Speakers at the meeting will include Professor Richard Sullivan (Kings College London), Dr Satish Gopal (NCI Center for Global Health, USA),. Professor Bhawna Sirohi (Apollo Proton Centre, Chennai India) and Mark Lodge (International Network for Cancer Treatment and Research UK). It is likely that the Network’s first project will be the mapping of the links between the UK and the low and middle income countries in the area of cancer control